Clinical Trial Update: BRCA 1/2 Mutation in Korean Patients With Epithelial Ovarian Cancer

View source ↗

Summary

A completed clinical trial assessing how common BRCA1/2 mutations are among Korean patients with ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Samsung Medical Center | Conditions: To Investigate the Prevalence of BRCA 1/2 Mutation Among Ovarian Cancer | Status: COMPLETED